抗ウイルス薬の世界市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Antiviral Drugs Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
PART 01: Executive summary

PART 02: Research Methodology

PART 03: Introduction
• Key market highlights
• Key vendor offerings

PART 04: Disease Overview
• Viral disease

PART 05: Market landscape
• Market overview
• Five forces analysis

PART 06: Pipeline analysis

PART 07: Market segmentation by therapies
• Global hepatitis therapeutics market
• Global HIV/AIDS therapeutics market
• Global herpes therapeutics market
• Global influenza therapeutics market

PART 08: Market segmentation by MOA
• Reverse transcriptase inhibitors
• Protease inhibitors
• Entry/Fusion inhibitors
• Immune system modulators

PART 09: Geographical segmentation
• Antiviral drugs market in Americas
• Antiviral drugs market in EMEA
• Antiviral drugs market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Forcefield analysis of impact of drivers and challenges

PART 12: Market trends
• Technological advancements
• Combination therapy
• Mergers and acquisitions
• Growing partnerships

PART 13: Competitive Landscape
• Competitive scenario

PART 14: Key vendor analysis
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• Gilead Sciences
• GlaxoSmithKline
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Few major products offered by the key vendors
Exhibit 02: HIV treatment regimen approved by FDA
Exhibit 03: Hepatitis treatment regimen approved by FDA
Exhibit 04: Herpes treatment regimen approved by FDA
Exhibit 05: Global antiviral drugs market snapshot
Exhibit 06: Key marketed products
Exhibit 07: Global antiviral drugs market 2016-2021 ($ billions)
Exhibit 08: Opportunity analysis of global antiviral drugs market
Exhibit 09: Snapshot of pipeline molecules (2016)
Exhibit 10: Pipeline analysis
Exhibit 11: Global antiviral drugs market segmentation by therapies
Exhibit 12: Acute hepatitis cases in US 2000-2014
Exhibit 13: Global hepatitis therapeutics market 2016-2021 ($ billions)
Exhibit 14: Global HIV/AIDS therapeutics market 2016-2021 ($ billions)
Exhibit 15: Number of women patients with HSV 2 in US 2000-2014
Exhibit 16: Global herpes therapeutic market 2016-2021 ($ billions)
Exhibit 17: Global influenza therapeutics market 2016-2021 ($ billions)
Exhibit 18: Global antiviral drugs market segmentation by MOA
Exhibit 19: Market share of different segments based on MOA 2016
Exhibit 20: Global antiviral drugs market segmentation by geography 2016 and 2021
Exhibit 21: Global antiviral drugs market revenue by geography 2016-2021 ($ billions)
Exhibit 22: Market scenario in Americas
Exhibit 23: Antiviral drugs market in Americas 2016-2021 ($ billions)
Exhibit 24: Market scenario in EMEA
Exhibit 25: Antiviral drugs market in EMEA 2016-2021 ($ billions)
Exhibit 26: Market scenario in APAC
Exhibit 27: Antiviral drugs market in APAC 2016-2021 ($ billions)
Exhibit 28: Seasonal influenza vaccine: Total doses distributed in millions
Exhibit 29: Impact of drivers
Exhibit 30: Impact of challenges
Exhibit 31: Competitive structure analysis of global antiviral drugs market 2016
Exhibit 32: Competitive analysis of global antiviral drugs market
Exhibit 33: Bristol-Myers Squibb: Geographical segmentation in terms of revenue in 2015
Exhibit 34: Bristol-Myers Squibb: Strength assessment
Exhibit 35: Bristol-Myers Squibb: Strategy assessment
Exhibit 36: Bristol-Myers Squibb: Opportunity assessment
Exhibit 37: F. Hoffman-La Roche: Strength assessment
Exhibit 38: F. Hoffman-La Roche: Strategy assessment
Exhibit 39: F. Hoffman-La Roche: Opportunity assessment
Exhibit 40: Gilead Sciences: Strength assessment
Exhibit 41: Gilead Sciences: Strategy assessment
Exhibit 42: Gilead Sciences: Opportunity assessment
Exhibit 43: GlaxoSmithKline: Strength assessment
Exhibit 44: GlaxoSmithKline: Strategy assessment
Exhibit 45: GlaxoSmithKline: Opportunity assessment


【レポート販売概要】

■ タイトル:抗ウイルス薬の世界市場2017-2021
■ 英文:Global Antiviral Drugs Market 2017-2021
■ 発行日:2017年3月8日
■ 調査会社:Technavio
■ 商品コード:IRTNTR11394
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。